Cargando…
Survival benefit of tamoxifen in male breast cancer: prospective cohort analysis
BACKGROUND: Due to the lack of prospective data, current treatment of male breast cancer (MBC) is based on information obtained from retrospective analysis or by extrapolation from studies on female patients. In this prospectively enrolled cohort study, we retrospectively examined the survival effec...
Autores principales: | Eggemann, Holm, Brucker, Cosima, Schrauder, Michael, Thill, Marc, Flock, Felix, Reinisch, Mattea, Costa, Serban-Dan, Ignatov, Atanas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341811/ https://www.ncbi.nlm.nih.gov/pubmed/32367072 http://dx.doi.org/10.1038/s41416-020-0857-z |
Ejemplares similares
-
Tamoxifen treatment for male breast cancer and risk of thromboembolism: prospective cohort analysis
por: Eggemann, Holm, et al.
Publicado: (2019) -
Endocrine Risk Factors of Endometrial Cancer: Polycystic Ovary Syndrome, Oral Contraceptives, Infertility, Tamoxifen
por: Ignatov, Atanas, et al.
Publicado: (2020) -
The impact of G protein-coupled oestrogen receptor 1 on male breast cancer: a retrospective analysis
por: Maiwald, Jan-Hendrik, et al.
Publicado: (2021) -
BCL3 expression is strongly associated with the occurrence of breast cancer relapse under tamoxifen treatment in a retrospective cohort study
por: Czapiewski, Piotr, et al.
Publicado: (2022) -
GPER-1 acts as a tumor suppressor in ovarian cancer
por: Ignatov, Tanja, et al.
Publicado: (2013)